← All organizations
Highest phase reached
Phase 1
First clinical trial
May 27, 2019Last known activity
Oct 5, 2020
Defunct as of Dec 31, 2025
Timeline
2010s
- Jan 1, 2018
Vallon Pharmaceuticals, Inc.— Founded
2020s
- Dec 13, 2023
GRI Bio, Inc.— Acquired - Dec 31, 2025
Vallon Pharmaceuticals, Inc.— Defunct
Drugs by trial phase (3 distinct, 3 trials)
Phase 2 (0 own, 1 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (4)
- NCT04647903Lead sponsorPhase 1Oct 5, 2020
- NCT04647903Study directorPhase 1Oct 5, 2020
- NCT04232644Lead sponsorPhase 1May 27, 2019
- NCT04232644Study directorPhase 1May 27, 2019
Details
- Founded
- Philadelphia, PA, US Jan 1, 2018
- Last known activity
- Oct 5, 2020